These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4224585)

  • 21. Erythroderma and pneumonitis induced by penicillin?
    Wengrower D; Tzfoni EE; Drenger B; Leitersdorf E
    Respiration; 1986; 50(4):301-3. PubMed ID: 2950581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe acute irritant contact dermatitis presenting as exfoliative erythroderma.
    Mose M; Sommerlund M; Koppelhus U
    Contact Dermatitis; 2013 Aug; 69(2):119-21. PubMed ID: 23869733
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-induced erythroderma with high fever--is it drug hypersensitivity syndrome?
    Schlienger RG; Bircher AJ
    J Dermatol; 2003 Apr; 30(4):344-5; discussion 345. PubMed ID: 12707474
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug-induced hypersensitivity due to phenytoin].
    Itomi S; Okumura A; Ikuta T; Suzuki Y; Kato T; Negoro T; Watanabe K
    No To Hattatsu; 2007 Sep; 39(5):356-9. PubMed ID: 17879609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diphenylhydantoin-induced hypersensitivity reaction with interstitial nephritis.
    Matson JR; Krous HF; Blackstock R
    Hum Pathol; 1985 Jan; 16(1):94-7. PubMed ID: 3156084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 27. Phenytoin in cutaneous medicine: its uses, mechanisms and side effects.
    Scheinfeld N
    Dermatol Online J; 2003 Aug; 9(3):6. PubMed ID: 12952753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the clinical features, histology and etiology of gingival hyperplasia and the hydantoins].
    Gottwald W
    Zahnarztl Welt Zahnarztl Rundsch ZWR Zahnarztl Reform; 1969 Jan; 78(1):24-9. PubMed ID: 4891586
    [No Abstract]   [Full Text] [Related]  

  • 29. Gingival hyperplasia related to treatment with diphenylhydantoin (diphedan; DH).
    Rudas SL; Bárdos FV
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):180-4. PubMed ID: 4308214
    [No Abstract]   [Full Text] [Related]  

  • 30. [Phenytoin hypersensitivity syndrome].
    García-Samaniego J; Soriano V; Soto J; Muñoz F
    An Med Interna; 1994 Nov; 11(11):541-2. PubMed ID: 7654902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gingival hyperplasia in epileptic patients treated with diphenylhydantoin. Study by light and electron microscopy].
    Tsutsumi V; Hara Ortíz F; Alvarez Fuertes G
    Rev Invest Salud Publica; 1973; 33(3-4):1-16. PubMed ID: 4791088
    [No Abstract]   [Full Text] [Related]  

  • 32. The multiple system effects of diphenylhydantoin (Dilantin).
    Lindall AW
    Minn Med; 1969 Feb; 52(2):337-44. PubMed ID: 5764821
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development.
    Drízhal I; Spacek J; Hrdinová V; Lichý J; Kaut V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):625-89. PubMed ID: 6972082
    [No Abstract]   [Full Text] [Related]  

  • 34. [Complications of medical therapy for epilepsy in children and adolescents].
    Skrotskiĭ IuA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(11):1710-4. PubMed ID: 4778243
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute renal failure and erythroderma caused by carbamazepine therapy].
    Ruiz Ezquerro JJ; Arcaya Navarro J; Díaz Molina H; Sánchez Estella J; de Diego Gómez JM
    An Med Interna; 1990 Apr; 7(4):216-7. PubMed ID: 2151749
    [No Abstract]   [Full Text] [Related]  

  • 36. [Severe diphenylhydantoin hypersensitivity: analysis of 11 cases].
    Pan CH; Tsai JJ; Chee CY; Hsi MS; Luo SF
    Taiwan Yi Xue Hui Za Zhi; 1987 Jul; 86(7):750-8. PubMed ID: 3681242
    [No Abstract]   [Full Text] [Related]  

  • 37. Interstitial granulomatous drug reaction presenting as erythroderma: remission after discontinuation of enalapril maleate.
    Chen YC; Hsiao CH; Tsai TF
    Br J Dermatol; 2008 May; 158(5):1143-5. PubMed ID: 18284384
    [No Abstract]   [Full Text] [Related]  

  • 38. Peripheral neuropathy in long-term diphenylhydantoin therapy.
    Lovelace RE; Horwitz SJ
    Trans Am Neurol Assoc; 1967; 92():262-4. PubMed ID: 4329415
    [No Abstract]   [Full Text] [Related]  

  • 39. [Exfoliative erythroderma after taking the Elsinore pill and accidental induction with ephedrine nose drops].
    Serup J
    Ugeskr Laeger; 1981 Jun; 143(26):1660-2. PubMed ID: 6457428
    [No Abstract]   [Full Text] [Related]  

  • 40. Ethylenediamine-induced exfoliative erythroderma.
    Bernstein JE; Lorincz AL
    Arch Dermatol; 1979 Mar; 115(3):360-1. PubMed ID: 155424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.